MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-14-2025
OptiNose Historical Prices 2011-2026 | OPTN
Annual Historical Prices OptiNose
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.71 | 1.83 | 1.62 | 4.14 | 9.22 | 6.2 | 18.9 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.9 | 1.62 | 6.23 |
Historical Prices of other stocks in the Drug manufacturers industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
0.86 | - | 7.5 % | $ 6.35 M |  USA |
 |
DURECT Corporation
DRRX
|
1.21 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
0.12 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
7.02 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
0.6 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
3.97 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
3.69 | $ 2.63 | -0.75 % | $ 1.35 B |  Canada |
 |
Athenex
ATNX
|
1.75 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
7.54 | - | - | $ 2.06 B |  France |
 |
Cumberland Pharmaceuticals
CPIX
|
6.3 | $ 4.55 | 0.44 % | $ 64 M | USA |
 |
Catalent
CTLT
|
60 | - | - | $ 11.5 B | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
19.7 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
0.71 | - | 2.45 % | $ 38.1 M | Canada |
 |
Eagle Pharmaceuticals
EGRX
|
26.3 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
0.29 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
0.67 | - | - | $ 36.6 M | USA |
 |
Bausch Health Companies
BHC
|
9.27 | $ 5.64 | 2.17 % | $ 2.06 B | Canada |
 |
Canopy Growth Corporation
CGC
|
1.32 | $ 1.08 | -1.82 % | $ 116 M | Canada |
 |
Harrow Health
HROW
|
52.6 | $ 40.5 | 0.75 % | $ 1.49 B | USA |
 |
Aurora Cannabis
ACB
|
4.08 | $ 3.44 | 0.58 % | $ 86.3 M | Canada |
 |
Jupiter Wellness
JUPW
|
1.52 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
0.57 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
1.58 | $ 1.39 | - | $ 402 M | Canada |
 |
Evolus
EOLS
|
4.21 | $ 6.37 | 14.16 % | $ 411 M | USA |
 |
Sundial Growers
SNDL
|
1.35 | $ 1.43 | 0.7 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
2.71 | $ 9.05 | 5.97 % | $ 463 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
3.49 | - | - | $ 193 M | Canada |
 |
Organogenesis Holdings
ORGO
|
3.15 | $ 2.59 | 1.17 % | $ 341 M | USA |
 |
Pacira BioSciences
PCRX
|
25.5 | $ 24.79 | 0.41 % | $ 1.15 B | USA |
 |
ProPhase Labs
PRPH
|
8.24 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
8.32 | - | - | $ 1.42 B | USA |
 |
Assertio Holdings
ASRT
|
11.8 | $ 22.16 | 2.55 % | $ 142 M | USA |
 |
PetIQ
PETQ
|
13.6 | - | 1.64 % | $ 400 M | USA |
 |
Solid Biosciences
SLDB
|
7.12 | $ 6.9 | -4.56 % | $ 604 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
2.95 | $ 1.23 | 0.82 % | $ 1.53 M | USA |
 |
Relmada Therapeutics
RLMD
|
6.25 | $ 7.35 | -0.81 % | $ 290 M | USA |
 |
Recro Pharma
REPH
|
1.4 | - | -4.76 % | $ 65.3 M | USA |
 |
Tilray
TLRY
|
1.93 | $ 5.69 | -3.56 % | $ 3.52 B | Canada |
 |
SCYNEXIS
SCYX
|
0.76 | $ 0.94 | -4.2 % | $ 46.9 M | USA |
 |
PLx Pharma
PLXP
|
5.05 | - | -27.8 % | $ 2.56 M | USA |
 |
Veru
VERU
|
0.8 | $ 2.21 | -1.78 % | $ 298 M | USA |
 |
Viatris
VTRS
|
15.3 | $ 15.52 | 2.11 % | $ 18.6 B | USA |
 |
cbdMD
YCBD
|
0.39 | $ 0.85 | -0.69 % | $ 3.67 M | USA |
 |
Zomedica Corp.
ZOM
|
0.14 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.44 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
0.94 | $ 0.86 | -3.34 % | $ 30.9 M | USA |
 |
Tricida
TCDA
|
7.96 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
0.64 | $ 0.53 | 2.87 % | $ 2.27 M |  China |
 |
TherapeuticsMD
TXMD
|
1.99 | $ 2.07 | 2.48 % | $ 23.9 M | USA |